rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David A. Fellows

Director

Company insider

Files Form 4 as: Director, Terns Pharmaceuticals; Chief Executive Officer, Nightstar Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
34
Buys
0
Sells
3
Bought
$0
Sold
$462K
Companies
2
Companies where not an officer
1
First trade
7 Jan 2019
Last trade
5 May 2026
Last filed
5 May 2026

Companies traded

Where they are an officer
Nightstar TherapeuticsDirector, Officer · last 7 Jun 20190 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Terns PharmaceuticalsDirector · Biotechnology · last 5 May 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—45,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—18,650filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—45,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—18,650filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—8,183filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—28,475filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—22,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—2,828filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—8,183filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—28,475filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—22,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—32,000filing
5 May 2026filed 5 May 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—2,828filing
1 Feb 2026filed 2 Feb 2026Terns Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—2,828 at $0.00filing
1 Feb 2026filed 2 Feb 2026Terns Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—2,828 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.